XOMA Royalty Corp
XOMA36.430USD
-2.340-6.04%
Close 10/10, 16:00（ET）Quotes delayed by 15 min
439.44MMarket Cap
LossP/E TTM
More Details of XOMA Royalty Corp Company
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to larger pharmaceutical partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's royalty portfolio includes OJEMDA (tovorafenib), JNJ-63723283 (cetrelimab), RZ358, arimoclomol, mezagitamab (TAK-079), acimtamig (AFM13), AB054, ficlatuzumab (AV-299), COM902, vosaroxin, aldoxorubicin, INCAGN02385, INCAGN02390, MNPR-101, PBF-680, PBF-677, PBF-999, PBF-1129, PBF-1650, RZ402, DSUVIA (sufentanil sublingual tablet), IXINITY [coagulation factor IX (recombinant)], CMP-001 (vidutolimod), NTM-1631, NTM-1634, NTM-1633, NTM-1632, NIR178, MK-4830, AFM24, INCAGN01949, AB101, and CFZ533 (iscalimab).
XOMA Royalty Corp Info
Ticker SymbolXOMA
Company nameXOMA Royalty Corp
IPO dateJun 06, 1986
CEOMr. Owen P. Hughes, Jr.
Number of employees13
Security typeOrdinary Share
Fiscal year-endJun 06
Address2200 Powell Street
CityEMERYVILLE
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code94608
Phone15102047239
Websitehttps://www.xoma.com/
Ticker SymbolXOMA
IPO dateJun 06, 1986
CEOMr. Owen P. Hughes, Jr.
Company Executives of XOMA Royalty Corp
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
United States
7.37M
56.14%
Switzerland
5.76M
43.86%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, Aug 15
Updated: Fri, Aug 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BVF Partners L.P.
21.43%
Morgan Stanley Investment Management Inc. (US)
12.61%
Fidelity Management & Research Company LLC
8.59%
The Vanguard Group, Inc.
5.28%
BlackRock Institutional Trust Company, N.A.
4.47%
Other
47.61%
Shareholders
Shareholders
Proportion
BVF Partners L.P.
21.43%
Morgan Stanley Investment Management Inc. (US)
12.61%
Fidelity Management & Research Company LLC
8.59%
The Vanguard Group, Inc.
5.28%
BlackRock Institutional Trust Company, N.A.
4.47%
Other
47.61%
Shareholder Types
Shareholders
Proportion
Hedge Fund
25.40%
Investment Advisor
23.07%
Investment Advisor/Hedge Fund
19.17%
Individual Investor
1.84%
Research Firm
0.23%
Bank and Trust
0.08%
Pension Fund
0.05%
Insurance Company
0.03%
Other
30.12%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
136
8.23M
68.05%
+572.72K
2025Q2
147
7.87M
65.79%
+337.12K
2025Q1
150
7.99M
66.81%
+297.02K
2024Q4
151
7.96M
67.53%
-445.61K
2024Q3
149
7.79M
66.29%
-572.80K
2024Q2
143
7.78M
66.74%
-664.29K
2024Q1
144
7.71M
66.30%
-615.38K
2023Q4
149
7.62M
66.29%
-820.22K
2023Q3
146
7.80M
68.02%
-670.64K
2023Q2
148
7.93M
69.11%
+32.68K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BVF Partners L.P.
2.59M
21.43%
--
--
Jun 30, 2025
Morgan Stanley Investment Management Inc. (US)
1.52M
12.61%
+420.58K
+38.09%
Jun 30, 2025
Fidelity Management & Research Company LLC
1.04M
8.59%
+126.00
+0.01%
Jun 30, 2025
The Vanguard Group, Inc.
638.81K
5.28%
+179.72K
+39.15%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
540.12K
4.47%
+49.52K
+10.09%
Jun 30, 2025
Opaleye Management Inc.
255.09K
2.11%
+2.04K
+0.81%
Jun 30, 2025
Geode Capital Management, L.L.C.
203.60K
1.68%
+16.93K
+9.07%
Jun 30, 2025
Woodline Partners LP
180.23K
1.49%
+11.68K
+6.93%
Jun 30, 2025
State Street Global Advisors (US)
153.48K
1.27%
+8.76K
+6.05%
Jun 30, 2025
Stonepine Capital Management, LLC
152.14K
1.26%
+22.33K
+17.20%
Jun 30, 2025
View more
Related ETFs
Updated: Mon, Oct 6
Updated: Mon, Oct 6
Name
Proportion
iShares Micro-Cap ETF
0.06%
ProShares Hedge Replication ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Avantis US Small Cap Equity ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.06%
ProShares Hedge Replication ETF
Proportion0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
iShares Russell 2000 Value ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
Avantis US Small Cap Equity ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
